Cargando…

Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment

BACKGROUND: The aim of this study was to determine influence of prognostic factors in addition to UICC staging systems, on cancer-specific and overall survival rates for patients with colorectal cancer (CRC) undergoing surgical treatment. METHODS: Between January 1996 and December 2006, a total of 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Li-Chu, Chu, Koung-Shing, Cheng, Su-Chen, Lu, Chien-Yu, Kuo, Chao-Hung, Hsieh, Jan-Sing, Shih, Ying-Ling, Chang, Shun-Jen, Wang, Jaw-Yuan
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745428/
https://www.ncbi.nlm.nih.gov/pubmed/19691850
http://dx.doi.org/10.1186/1471-2407-9-288
_version_ 1782171965913563136
author Sun, Li-Chu
Chu, Koung-Shing
Cheng, Su-Chen
Lu, Chien-Yu
Kuo, Chao-Hung
Hsieh, Jan-Sing
Shih, Ying-Ling
Chang, Shun-Jen
Wang, Jaw-Yuan
author_facet Sun, Li-Chu
Chu, Koung-Shing
Cheng, Su-Chen
Lu, Chien-Yu
Kuo, Chao-Hung
Hsieh, Jan-Sing
Shih, Ying-Ling
Chang, Shun-Jen
Wang, Jaw-Yuan
author_sort Sun, Li-Chu
collection PubMed
description BACKGROUND: The aim of this study was to determine influence of prognostic factors in addition to UICC staging systems, on cancer-specific and overall survival rates for patients with colorectal cancer (CRC) undergoing surgical treatment. METHODS: Between January 1996 and December 2006, a total of 1367 CRC patients who underwent surgical treatment in Kaohsiung Medical University Hospital were analyzed. We retrospectively investigated clinicopathologic features of these patients. All patients were followed up intensively, and their outcomes were investigated completely. RESULTS: Of 1367 CRC patients, there were seven hundred and fifty-seven males (55.4%) and 610 (44.6%) females. The median follow-up period was 60 months (range, 3–132 months). A multivariate analysis identified that low serum albumin level (P = 0.011), advanced UICC stage (P < 0.001), and high carcinoembryonic antigen (CEA) level (P < 0.001) were independent prognostic factors of cancer-specific survival. Meanwhile, a multivariate analysis showed age over 65 years (P < 0.001), advanced UICC stage (P < 0.001), and high CEA level (P < 0.001) were independent prognostic factors of overall survival. Furthermore, combination of UICC stage, serum CEA and albumin levels as predictors of cancer-specific survival showed that the poorer the prognostic factors involved, the poorer the cancer-specific survival rate. Likewise, combination of UICC stage, age and serum CEA level as predictors of overall survival showed that the poorer the prognostic factors involved, the poorer the overall survival rate. Of these prognostic factors, preoperative serum CEA level was the only significant prognostic factor for patients with stage II and III CRCs in both cancer-specific and overall survival categories. CONCLUSION: Preoperative serum albumin level, CEA level and age could prominently affect postoperative outcome of CRC patients undergoing surgical treatment. In addition to conventional UICC staging system, it might be imperative to take these additional characteristics of factors into account in CRC patients prior to surgical treatment.
format Text
id pubmed-2745428
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27454282009-09-17 Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment Sun, Li-Chu Chu, Koung-Shing Cheng, Su-Chen Lu, Chien-Yu Kuo, Chao-Hung Hsieh, Jan-Sing Shih, Ying-Ling Chang, Shun-Jen Wang, Jaw-Yuan BMC Cancer Research Article BACKGROUND: The aim of this study was to determine influence of prognostic factors in addition to UICC staging systems, on cancer-specific and overall survival rates for patients with colorectal cancer (CRC) undergoing surgical treatment. METHODS: Between January 1996 and December 2006, a total of 1367 CRC patients who underwent surgical treatment in Kaohsiung Medical University Hospital were analyzed. We retrospectively investigated clinicopathologic features of these patients. All patients were followed up intensively, and their outcomes were investigated completely. RESULTS: Of 1367 CRC patients, there were seven hundred and fifty-seven males (55.4%) and 610 (44.6%) females. The median follow-up period was 60 months (range, 3–132 months). A multivariate analysis identified that low serum albumin level (P = 0.011), advanced UICC stage (P < 0.001), and high carcinoembryonic antigen (CEA) level (P < 0.001) were independent prognostic factors of cancer-specific survival. Meanwhile, a multivariate analysis showed age over 65 years (P < 0.001), advanced UICC stage (P < 0.001), and high CEA level (P < 0.001) were independent prognostic factors of overall survival. Furthermore, combination of UICC stage, serum CEA and albumin levels as predictors of cancer-specific survival showed that the poorer the prognostic factors involved, the poorer the cancer-specific survival rate. Likewise, combination of UICC stage, age and serum CEA level as predictors of overall survival showed that the poorer the prognostic factors involved, the poorer the overall survival rate. Of these prognostic factors, preoperative serum CEA level was the only significant prognostic factor for patients with stage II and III CRCs in both cancer-specific and overall survival categories. CONCLUSION: Preoperative serum albumin level, CEA level and age could prominently affect postoperative outcome of CRC patients undergoing surgical treatment. In addition to conventional UICC staging system, it might be imperative to take these additional characteristics of factors into account in CRC patients prior to surgical treatment. BioMed Central 2009-08-20 /pmc/articles/PMC2745428/ /pubmed/19691850 http://dx.doi.org/10.1186/1471-2407-9-288 Text en Copyright ©2009 Sun et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Sun, Li-Chu
Chu, Koung-Shing
Cheng, Su-Chen
Lu, Chien-Yu
Kuo, Chao-Hung
Hsieh, Jan-Sing
Shih, Ying-Ling
Chang, Shun-Jen
Wang, Jaw-Yuan
Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment
title Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment
title_full Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment
title_fullStr Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment
title_full_unstemmed Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment
title_short Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment
title_sort preoperative serum carcinoembryonic antigen, albumin and age are supplementary to uicc staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745428/
https://www.ncbi.nlm.nih.gov/pubmed/19691850
http://dx.doi.org/10.1186/1471-2407-9-288
work_keys_str_mv AT sunlichu preoperativeserumcarcinoembryonicantigenalbuminandagearesupplementarytouiccstagingsystemsinpredictingsurvivalforcolorectalcancerpatientsundergoingsurgicaltreatment
AT chukoungshing preoperativeserumcarcinoembryonicantigenalbuminandagearesupplementarytouiccstagingsystemsinpredictingsurvivalforcolorectalcancerpatientsundergoingsurgicaltreatment
AT chengsuchen preoperativeserumcarcinoembryonicantigenalbuminandagearesupplementarytouiccstagingsystemsinpredictingsurvivalforcolorectalcancerpatientsundergoingsurgicaltreatment
AT luchienyu preoperativeserumcarcinoembryonicantigenalbuminandagearesupplementarytouiccstagingsystemsinpredictingsurvivalforcolorectalcancerpatientsundergoingsurgicaltreatment
AT kuochaohung preoperativeserumcarcinoembryonicantigenalbuminandagearesupplementarytouiccstagingsystemsinpredictingsurvivalforcolorectalcancerpatientsundergoingsurgicaltreatment
AT hsiehjansing preoperativeserumcarcinoembryonicantigenalbuminandagearesupplementarytouiccstagingsystemsinpredictingsurvivalforcolorectalcancerpatientsundergoingsurgicaltreatment
AT shihyingling preoperativeserumcarcinoembryonicantigenalbuminandagearesupplementarytouiccstagingsystemsinpredictingsurvivalforcolorectalcancerpatientsundergoingsurgicaltreatment
AT changshunjen preoperativeserumcarcinoembryonicantigenalbuminandagearesupplementarytouiccstagingsystemsinpredictingsurvivalforcolorectalcancerpatientsundergoingsurgicaltreatment
AT wangjawyuan preoperativeserumcarcinoembryonicantigenalbuminandagearesupplementarytouiccstagingsystemsinpredictingsurvivalforcolorectalcancerpatientsundergoingsurgicaltreatment